imiquimod has been researched along with glycosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, T; Li, P; Liang, D; Liu, X; Wang, Y; Zhang, G; Zhao, J | 1 |
| Jeon, YJ; Kim, TY; Lee, JH; Sah, SK; Shin, J; Yang, HS | 1 |
2 other study(ies) available for imiquimod and glycosides
| Article | Year |
|---|---|
Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Topics: Aminoquinolines; Animals; CD4-Positive T-Lymphocytes; Cytokines; Gene Expression; Glycosides; Imiquimod; Immunohistochemistry; Inflammation; Inflammation Mediators; Interleukin-17; Mice, Inbred BALB C; Phosphorylation; Phytotherapy; Protective Agents; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; Skin; Skin Diseases; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells; Tripterygium | 2016 |
Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Glycosides; Humans; Imiquimod; Keratinocytes; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NF-kappa B; Phenols; Primary Cell Culture; Psoriasis; Rhododendron; RNA, Messenger; Skin; Toll-Like Receptor 7 | 2017 |